Previous 10 |
LAS VEGAS, May 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC PINK:BDPT) announced Dr. James Rouse has been appointed to the board of Directors and accepted the position of President. He will start serving in both roles effective immediately. Dr. James, as he is fondly known, is a fun...
LAS VEGAS, March 22, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc., an OTC public company trading under the ticker symbol BDPT (OTCPink) announced that it has signed a Letter of Intent with1682593 Ontario Limited to acquire the assets of Philco Animal Health Inc. Philco Animal Health is a ...
LAS VEGAS, March 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc., a fully-reporting public company trading under the ticker symbol BDPT (OTC PINK:BDPT) announced that Mr. Kim D. Southworth has assumed the position of Chief Executive Officer of the Company upon the resignation of Mr. Christo...
News, Short Squeeze, Breakout and More Instantly...
LAS VEGAS, NV, April 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the intention to spin off its Livestock Impact Division as a wholly-owned subsidiary. The new company will continue to develop and market natural suppleme...
Las Vegas, NV - ( NewMediaWire ) - April 18, 2023 - BioAdaptives, Inc. (OTCMkts: BDPT) announced today the signing of a non-exclusive license agreement with LY Research Corporation to market a patented resveratrol product (patent US # 6,855,353) for animals and humans. Edward Jacobs, M...
Las Vegas, NV - ( NewMediaWire ) - April 13, 2023 - BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment of David Allen, PhD to its Board of Directors. Edward Jacobs, M.D., CEO BioAdaptives, Inc., comments, “We are very pleased to be joined by David Allen, PhD on our Boa...